Chronic Wasting Disease Spreads Silently in Symptom-Free Animals, Raising Questions About Long-Term Human Risk

1. A University of Calgary study published in Science Advances this month found that chronic wasting disease can spread silently in animals with no clinical symptoms, and demonstrated limited but detectable cross-species prion transmission in nonhuman primate models.

2. There are no confirmed human cases, but the expanding geographic footprint of the disease in wild cervid populations means the cumulative exposure risk is rising, and public health experts say this study reinforces the case for sustained surveillance.

Chronic wasting disease gets less public health attention than it probably deserves. It affects deer, elk, moose, and caribou rather than livestock or people, no human case has ever been confirmed, and the prion field does not generate the same media urgency as influenza or emerging viruses. A paper published in June 2026 in Science Advances by University of Calgary researchers and international collaborators adds findings that warrant closer attention. The first is that animals with no visible clinical symptoms can shed infectious prions, meaning surveillance programs that look for sick animals are systematically undercounting how widely the disease has spread in wild populations. The second is that in experimental settings, cervid prions showed limited but real transmission to nonhuman primates, and displayed capacity for adaptation under laboratory conditions. The researchers are careful not to overstate this. As they noted in the paper, their findings do not indicate an immediate risk to humans. But the situation is more nuanced than previously understood. There has never been a confirmed human case, and the species barrier between cervids and humans currently appears strong. What the Center for Infectious Disease Research and Policy at the University of Minnesota has consistently pointed out, however, is that prion diseases are uniformly fatal with no treatment options, that species barriers can change as prions evolve in large infected reservoirs, and that the comparison to BSE is not a rhetorical device but a cautionary historical precedent. The more the disease spreads in animals, the more human exposure opportunities accumulate, and exposure risk scales with prevalence. For clinicians, none of this changes the guidance for patients who hunt in affected states, but it does make it worth giving that guidance proactively: have harvested animals tested where state programs exist, avoid consuming meat from animals that appear sick, use gloves when field dressing carcasses, and avoid contact with the brain, spinal cord, eyes, and lymph nodes where prion concentrations are highest. The concern here is not about an imminent threat. It is about what happens when a fatal untreatable disease keeps expanding in a large wild animal population over the next decade, and whether the public health infrastructure to detect and respond to a species jump will exist when it matters.